Product InnovationNovasight combines the two most common intravascular imaging modalities, which are crucial for guiding angioplasty and stenting of patients with coronary artery disease.

Regulatory ApprovalConavi is well-positioned to receive FDA clearance and launch its next generation Novasight Hybrid System.

Bears Say

Competitive RisksKey risks include competitive and balance sheet risks.

Conavi Medical News

Conavi Medical Strengthens Leadership for U.S. Expansion

The latest announcement is out from Conavi Medical ( ($TSE:CNVI) ). Conavi Medical has announced strategic leadership changes...

1M ago

Conavi Medical Secures Funding for Next-Gen Cardiovascular Imaging System

The latest update is out from Conavi Medical ( ($TSE:CNVI) ). Conavi Medical has secured an agreement with...

2M ago

Conavi Medical to Showcase Novasight Hybrid™ Imaging at TCT 2025

Conavi Medical ( ($TSE:CNVI) ) has shared an announcement. Conavi Medical announced its participation in the Transcatheter Cardiovascular...

2M ago

Conavi Medical to Present at Planet MicroCap Showcase in Toronto

The latest announcement is out from Conavi Medical ( ($TSE:CNVI) ). Conavi Medical Corp. announced its participation in...

2M ago

Conavi Medical Seeks FDA Clearance for Next-Gen Intravascular Imaging System

Conavi Medical ( ($TSE:CNVI) ) has provided an update. Conavi Medical has submitted its next-generation Novasight Hybrid intravascular...

3M ago

Conavi Medical Advances Towards U.S. Launch with Strong Q3 2025 Results

An announcement from Conavi Medical ( ($TSE:CNVI) ) is now available. Conavi Medical announced its fiscal Q3 2025...

4M ago

Conavi Medical’s Novasight™ System Validated in Complex Coronary Case

Conavi Medical ( ($TSE:CNVI) ) has shared an announcement. Conavi Medical announced a case report published in the...

5M ago

Conavi Medical Applauds Study on Intracoronary Imaging Importance

The latest update is out from Conavi Medical ( ($TSE:CNVI) ). Conavi Medical highlights a new study in...

5M ago

Promising Growth Ahead: Buy Rating for Conavi Medical Amidst Anticipated FDA Approval and Market Expansion

David Martin PhD, an analyst from Bloom Burton, has initiated a new Buy rating on Conavi Medical (CNVIF)....

5M ago

Conavi Medical Corp. to Host Investor Webinar on Innovative Cardiovascular Imaging Technology

Conavi Medical ( ($TSE:CNVI) ) has issued an announcement. Conavi Medical Corp. announced an upcoming investor webinar featuring...

6M ago

CNVI FAQ

What was Conavi Medical’s price range in the past 12 months?

Conavi Medical lowest stock price was C$0.35 and its highest was C$0.83 in the past 12 months.

What is Conavi Medical’s market cap?

Conavi Medical’s market cap is $28.86M.

When is Conavi Medical’s upcoming earnings report date?

Conavi Medical’s upcoming earnings report date is Dec 18, 2025 which is in 5 days.

How were Conavi Medical’s earnings last quarter?

Conavi Medical released its earnings results on Aug 29, 2025. The company reported -C$0.05 earnings per share for the quarter, beating the consensus estimate of -C$0.051 by C$0.001.

Is Conavi Medical overvalued?

According to Wall Street analysts Conavi Medical’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Conavi Medical pay dividends?

Conavi Medical does not currently pay dividends.

What is Conavi Medical’s EPS estimate?

Conavi Medical’s EPS estimate is -0.05.

How many shares outstanding does Conavi Medical have?

Conavi Medical has 53,441,880 shares outstanding.

What happened to Conavi Medical’s price movement after its last earnings report?

Conavi Medical reported an EPS of -C$0.05 in its last earnings report, beating expectations of -C$0.051. Following the earnings report the stock price went down -2.247%.

Which hedge fund is a major shareholder of Conavi Medical?

Currently, no hedge funds are holding shares in TSE:CNVI

Company Description

Conavi Medical

Titan Medical, Inc. engages in the designing, development, and commercialization of new robotic surgical technologies. It focuses on developing Sport Surgical System, which is a single incision robotic surgical system that features multi-articulated instruments with single-use replaceable tips, and 3D display. The company was founded on July 28, 2008 and is headquartered in Toronto, Canada.